Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tiny study to test how Ultra-Processed foods affect weight and health

NCT ID NCT07318064

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 30, 2026 · Updated 4 times

Summary

This pilot study will compare two diets—one high in ultra-processed foods and one typical American diet—in 6 adults with overweight or obesity. Participants will try each diet for two weeks in random order. The goal is not to prove which diet is better, but to see if a larger study is possible and to estimate how many people would be needed for future research.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dietary intervention (ultra-processed food diet vs. typical American diet)
What this could lead to
If successful, this pilot could provide the necessary data to design a larger trial that may clarify how ultra-processed foods affect health.
What could go wrong
This is a very small pilot study with only 6 participants and a short 2-week diet period, so results may not apply to the general population or show clear health effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 6 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Overweight or obesity (BMI 25-50 kg/m2) * Willingness to accept group assignment and provide outcome measures * Premenopausal (women only) * Be able to communicate (oral and written) in English * Be able to provide informed consent Exclusion Criteria: * Recent weight loss (≥10 pounds in the last six months) * On a regimen of medications (weight loss or otherwise) that can affect weight or diabetes outcomes for less than 3 months (GLP1 medications allowed if weight stable and on stable dose for \>=3 months) * Given birth within the past year or is currently pregnant or breastfeeding * Past bariatric surgery (\<10 years) - all types * Disease/condition that is life threatening or can interfere with or be aggravated by weight change * Dementia, psychiatric illness, or substance abuse that may interfere with adherence * Current or history of a clinically diagnosed eating disorder, including anorexia nervosa or bulimia nervosa * Type 1 or type 2 diabetes * Uncontrolled gastrointestinal disorders including chronic malabsorptive conditions, peptic ulcer disease, Crohn's disease, chronic diarrhea or active gallbladder disease * Current cancer or cancer treatment, or a history of cancer or cancer treatment within the last 3 years. Exceptions include 1) successfully resected non-melanoma carcinoma of the skin, 2) basal or squamous cell skin cancer, 3) stage 0 non-invasive carcinoma of the cervix, 4) stage 0 non-invasive prostate cancer * History of kidney or liver disease or malnutrition that in investigator judgment should exclude participation * Hemoglobinopathy that interferes with measurement of HbA1c * Class II or higher congestive heart failure * Unstable heart disease * Blood pressure ≥160/100 mm Hg * Thyroid disease for which the participant is untreated or has had treatment changed within the last 6 weeks. * Unwilling to stop alcohol intake during study participation * Current smoker or other type of tobacco user (chewing tobacco, vaping, etc.) * Any other condition or factor which in the opinion of the study physician or investigator makes it inadvisable for the candidate to participate in the trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity & overweight are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana, 70810, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.